Dr. Kulvinder Kochar Kaur, Dr. Gautam Allahbadia, Dr. Mandeep Singh
{"title":"SGLT2抑制剂联合二甲双胍作为2型糖尿病初始治疗的作用——口服固定药物如恩格列清/二甲双胍在心血管和肾脏风险患者中的优势——简短交流","authors":"Dr. Kulvinder Kochar Kaur, Dr. Gautam Allahbadia, Dr. Mandeep Singh","doi":"10.22259/2638-4981.0201002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":447189,"journal":{"name":"Archives of Diabetes and Endocrine System","volume":"592 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Role of Combination Therapy with SGLT2 Inhibitor with Metformin as Initial Treatment for Type2 Diabetes-Advantages of Oral Fixed Drug Pill Like Empagliflozin/Metformin in Patients with Cardiovascular and Renal Risk-A Short Communication\",\"authors\":\"Dr. Kulvinder Kochar Kaur, Dr. Gautam Allahbadia, Dr. Mandeep Singh\",\"doi\":\"10.22259/2638-4981.0201002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":447189,\"journal\":{\"name\":\"Archives of Diabetes and Endocrine System\",\"volume\":\"592 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Diabetes and Endocrine System\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22259/2638-4981.0201002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Diabetes and Endocrine System","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22259/2638-4981.0201002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Role of Combination Therapy with SGLT2 Inhibitor with Metformin as Initial Treatment for Type2 Diabetes-Advantages of Oral Fixed Drug Pill Like Empagliflozin/Metformin in Patients with Cardiovascular and Renal Risk-A Short Communication